Excipient knowledgebase: Development of a comprehensive tool for understanding the disposition and interaction potential of common excipients
Abstract Although the use of excipients is widespread, a thorough understanding of the drug interaction potential of these compounds remains a frequent topic of current research. Not only can excipients alter the disposition of coformulated drugs, but it is likely that these effects on co‐administer...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/253be63d1edb4eceb745e2080720f664 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:253be63d1edb4eceb745e2080720f664 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:253be63d1edb4eceb745e2080720f6642021-11-19T15:35:30ZExcipient knowledgebase: Development of a comprehensive tool for understanding the disposition and interaction potential of common excipients2163-830610.1002/psp4.12668https://doaj.org/article/253be63d1edb4eceb745e2080720f6642021-08-01T00:00:00Zhttps://doi.org/10.1002/psp4.12668https://doaj.org/toc/2163-8306Abstract Although the use of excipients is widespread, a thorough understanding of the drug interaction potential of these compounds remains a frequent topic of current research. Not only can excipients alter the disposition of coformulated drugs, but it is likely that these effects on co‐administered drugs can reach to clinical significance leading to potential adverse effects or loss of efficacy. These risks can be evaluated through use of in silico methods of mechanistic modeling, including approaches, such as population pharmacokinetic (PK) and physiologically‐based PK modeling, which require a comprehensive understanding of the compounds to ensure accurate predictions. We established a knowledgebase of the available compound (or substance) and interaction‐specific parameters with the goal of providing a single source of physiochemical, in vitro, and clinical PK and interaction data of commonly used excipients. To illustrate the utility of this knowledgebase, a model for cremophor EL was developed and used to hypothesize the potential for CYP3A‐ and P‐gp‐based interactions as a proof of concept.Savannah J. McFeelyJingjing YuYan WangCheryl WuIsabelle Ragueneau‐MajlessiWileyarticleTherapeutics. PharmacologyRM1-950ENCPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 8, Pp 953-961 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Therapeutics. Pharmacology RM1-950 |
spellingShingle |
Therapeutics. Pharmacology RM1-950 Savannah J. McFeely Jingjing Yu Yan Wang Cheryl Wu Isabelle Ragueneau‐Majlessi Excipient knowledgebase: Development of a comprehensive tool for understanding the disposition and interaction potential of common excipients |
description |
Abstract Although the use of excipients is widespread, a thorough understanding of the drug interaction potential of these compounds remains a frequent topic of current research. Not only can excipients alter the disposition of coformulated drugs, but it is likely that these effects on co‐administered drugs can reach to clinical significance leading to potential adverse effects or loss of efficacy. These risks can be evaluated through use of in silico methods of mechanistic modeling, including approaches, such as population pharmacokinetic (PK) and physiologically‐based PK modeling, which require a comprehensive understanding of the compounds to ensure accurate predictions. We established a knowledgebase of the available compound (or substance) and interaction‐specific parameters with the goal of providing a single source of physiochemical, in vitro, and clinical PK and interaction data of commonly used excipients. To illustrate the utility of this knowledgebase, a model for cremophor EL was developed and used to hypothesize the potential for CYP3A‐ and P‐gp‐based interactions as a proof of concept. |
format |
article |
author |
Savannah J. McFeely Jingjing Yu Yan Wang Cheryl Wu Isabelle Ragueneau‐Majlessi |
author_facet |
Savannah J. McFeely Jingjing Yu Yan Wang Cheryl Wu Isabelle Ragueneau‐Majlessi |
author_sort |
Savannah J. McFeely |
title |
Excipient knowledgebase: Development of a comprehensive tool for understanding the disposition and interaction potential of common excipients |
title_short |
Excipient knowledgebase: Development of a comprehensive tool for understanding the disposition and interaction potential of common excipients |
title_full |
Excipient knowledgebase: Development of a comprehensive tool for understanding the disposition and interaction potential of common excipients |
title_fullStr |
Excipient knowledgebase: Development of a comprehensive tool for understanding the disposition and interaction potential of common excipients |
title_full_unstemmed |
Excipient knowledgebase: Development of a comprehensive tool for understanding the disposition and interaction potential of common excipients |
title_sort |
excipient knowledgebase: development of a comprehensive tool for understanding the disposition and interaction potential of common excipients |
publisher |
Wiley |
publishDate |
2021 |
url |
https://doaj.org/article/253be63d1edb4eceb745e2080720f664 |
work_keys_str_mv |
AT savannahjmcfeely excipientknowledgebasedevelopmentofacomprehensivetoolforunderstandingthedispositionandinteractionpotentialofcommonexcipients AT jingjingyu excipientknowledgebasedevelopmentofacomprehensivetoolforunderstandingthedispositionandinteractionpotentialofcommonexcipients AT yanwang excipientknowledgebasedevelopmentofacomprehensivetoolforunderstandingthedispositionandinteractionpotentialofcommonexcipients AT cherylwu excipientknowledgebasedevelopmentofacomprehensivetoolforunderstandingthedispositionandinteractionpotentialofcommonexcipients AT isabelleragueneaumajlessi excipientknowledgebasedevelopmentofacomprehensivetoolforunderstandingthedispositionandinteractionpotentialofcommonexcipients |
_version_ |
1718420000014860288 |